4-[benzyl(tert-butoxycarbonyl)amino]butanoic acid, 95.0%, 25g

2-Amino-5-(4-chlorophenyl)-1,3,4-oxadiazole, 95.0%, 2.5g

Ester méthylique d'acide acétique, min.99%, pour la synthèse, 500 ml, emballage en verre

(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-4-(PYRIDIN-4-YL)BUTANOIC ACID, 95.0%, 250mg

3-methyl-6-(piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione, 95.0%, 500mg

5-Formyl-2-(piperidin-1-yl)benzonitrile, 97%, 1g

3-Fluoro-4-iodobenzaldehyde, 95.0%, 1g

2-(4-Amino-3-chlorophenyl)butanoic acid, 97.0%, 100mg

Methyl (R)-3-amino-3-(benzo[d][1,3]dioxol-5-yl)propanoate hydrochloride, 95%, 100mg

Benzo[d]isoxazole, 95.0%, 5g

(2R)-8-chloro-2-(trifluoromethyl)-2H,3H,4H,6H,7H-[1,3]diazino[1,2-a]pyrimidin-6-one, 98%, 25mg

6-(4-(Piperazin-1-yl)-3-(trifluoromethyl)phenyl)pyridazin-3(2H)-one, 98%, 1g

4-Amino-benzamide oxime, 97.0%, 25g